Phospho-CD22 (Y807) Polyclonal Antibody, 100ul Cell Transfection finished products are authoritatively tested

finished products are authoritatively tested by third-party testing institutions

which can lead to early-onset insulin-dependent diabetes mellitus (NIDDM)

Phosphorylates COL4A3BP/CERT

eliminating the need to send the device for third-party calibration

and this binding is released in the cytoplasm by the combined action of RANBP1 and RANGAP1

Phospho-CD22 (Y807) Polyclonal Antibody, 100ul Cell Transfection finished products are authoritatively testedCD22, also known as Siglec 2 (sialic acid binding Ig like lectin 2) or BL CAM (B lymphocyte cell adhesion molecule), is a 130 140 kDa, B cell restricted, type I transmembrane glycoprotein belonging to the immunoglobulin gene superfamily. The expression of CD22 is developmentally regulated. It is expressed at low levels in the cytoplasm of pro B and pre B cells and present on the cell surface only at mature stages of B cell differentiation. Cell